Lippo China res (00156) announced that the group is expected to recognize financial instruments at fair value through profit or loss for the six months ending on June 30, 2024...
The Lippo China res (00156) announced that the group is expected to incur a net fair value loss of not less than 50 million Hong Kong dollars for the six months ending on June 30, 2024, while it incurred a net fair value gain of 29 million Hong Kong dollars for the six months ending on June 30, 2023. Therefore, the board of directors anticipates a comprehensive loss attributable to shareholders of not less than 0.12 billion Hong Kong dollars for this period, compared to a comprehensive loss of 59 million Hong Kong dollars in the previous period.